Barclays 29 (FC31) News

That's good, but I'm compelled to post this one frequently because It's Pure Gold:

"“Far more money has been lost by investors trying to anticipate corrections,
than lost in the corrections themselves. ” Ascribed to Peter Lynch.

PLRZ News Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

PLRZ News Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Sure you do 🤡

Trump's ICE racks up hundreds of arrests, including illegal immigrants arrested for horror crimes

Over 460 arrests were made in the first 33 hours of the administration

https://www.foxnews.com/politics/trumps-ice-racks-up-hundreds-arrests-including-illegal-immigrants-ar

Downgrades - Jan 23, 2025

$VEEV - Goldman Sachs: Buy to Sell ($200 from $261)
$SAM - Piper Sandler: Overweight to Neutral ($275 from $370)
$EA - BMO Capital: Outperform to Market Perform ($145 from $160)
$EA - Raymond James: Outperform to Market Perform
$EA

Upgrades - Jan 23, 2025

$OPCH - Jefferies: Hold to Buy ($35 from $26)
$BOOT - KeyBanc: Sector Weight to Overweight ($190)
$RVLV - KeyBanc: Sector Weight to Overweight ($37)
$NFLX - Arete: Sell to Neutral ($833)
$NFLX - Wolfe: Peerperform to Outperform ($1,1

now everything is clear here ☺️

That's all they do. Blame everyone and everything for their misfortunes except for the company......smh

You can't even get the numbe right. It was over 90,000 emails. Lot's of folks were swindled in this scheme. Lot's of angry investors that lost it all.

2027 is the year that $AHRO is scheduled to give today's investors a very nice return imho

No could would should dude!! Make no mistake FOXO World leader in epigenetics AI Technologies
https://www.nature.com/articles/s41467-025-56331-w

Pump and dump?

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
LAS VEGAS, NV – January 23rd, 2025 – Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), an innovative topical pharmaceutical research and development company,

today announces

Waiting for the 3rd cohort news results!!!can be life changing

IBM
IBM price target raised to $233 from $227 at JPMorgan
JPMorgan raised the firm's price target on IBM to $233 from $227 and keeps a Neutral rating on the shares as part of a Q4 earnings preview. The firm expects "healthy" software and artificial intelligence business for Q4, offs

good morning 🌞🌞🌞🌞🌞🌞🌞🌞🌞🌞🌞

still hard to believe? how about when it hits $0.50ike you have been around log enough to know anything is possible with tmmi. I feel from what AI and fractal compression can accomplish, we are looking again at PPS hitting a buck. This could all happen before July of this year. merge Timmy with an e

Nice call Sickzone, The new business license is another step closer to first sales!!

“As for upcoming pr I expect Kim will pr the business license received this week in lam dong for Prodigy Silk .
.”

Our Father in heaven,
Hallowed be Your name.
Your kingdom come.
Your will be done
On earth as it is in heaven.
Give us this day our daily bread.
And forgive us our debts,
As we forgive our debtors.
And do not lead us into temptation,

Oh heck yeah. Big changes to the mobile version.

Version 7.0 is the best yet!  

Mods, please pin up yesterday's news. TIA

-
https://t.co/bjG3OVKhaN Investor Deck

https://investorshub.advfn.com/uimage/uploads/2025/1/23/bjycjGh8IgxLXcAAyPi-.jpg

Yeah - .0035 all in huh? For your sake I hope it blows by that in 2025 and you recoup your money. I now understand your frustration as my average is trip 6 and I can step out anytime... GLTY Ice.